The practice of brand-name manufacturers seeking to further extend the market exclusivity periods for their medicines to maintain revenue streams. Market exclusivity extensions may be achieved through a number of different strategies, often called ‘evergreening strategies’.
Last update: 21 June 2023
Source: PPRI